HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Austin Igelman Selected Research

bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amine

6/2018Preclinical development of anti-BCMA immunotoxins targeting multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Austin Igelman Research Topics

Disease

1Endophthalmitis (Ophthalmia)
01/2019
1Multiple Myeloma
06/2018

Drug/Important Bio-Agent (IBA)

1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
06/2018
1Immunotoxins (Immunotoxin)IBA
06/2018

Therapy/Procedure

1Intravitreal Injections
01/2019